A Pilot Study to Determine a Candidate Protocol for Transcranial Electrical Stimulation in the Treatment of Anxiety
NCT ID: NCT02321891
Last Updated: 2014-12-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
14 participants
INTERVENTIONAL
2014-12-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment 1
NeuroConn DC Stimulator Plus, tDCS treatment protocol no 1
NeuroConn DC Stimulator Plus, tDCS
transcranial electrical stimulation intervention with two experimental protocols
Treatment 2
NeuroConn DC Stimulator Plus, tDCS treatment protocol no 2
NeuroConn DC Stimulator Plus, tDCS
transcranial electrical stimulation intervention with two experimental protocols
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NeuroConn DC Stimulator Plus, tDCS
transcranial electrical stimulation intervention with two experimental protocols
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Naïve to tDCS
* Right-handed
* Beck Anxiety Scores \>= 26
Exclusion Criteria
* Severe skin lesions at the electrode placement area
* History of epilepsy or previous seizures
* Pregnant or breast-feeding
* Pacemaker
* History of intracerebral bleeding during the past six months
* Lifetime DSM-IV diagnosis of bipolar mood disorder or psychotic disorder
* DSM-IV diagnosis for substance abuse or dependence during the past six months
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Eastern Finland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Soili Lehto
Adjunct professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Soili M Lehto, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Eastern Finland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Eastern Finland
Kuopio, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Soili M Lehto, MD, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OptES-Anx-pilot
Identifier Type: -
Identifier Source: org_study_id